Today: September 20, 2024
Today: September 20, 2024

Fed's Powell leans hawkish in IMF remarks

Federal Reserve Chairman Jerome Powell holds a press conference in Washington
April 26, 2024
Reuters

NEW YORK (Reuters) - U.S. Federal Reserve officials "are not confident" that interest rates are yet high enough to finish the battle with inflation, and may be nearing the end of how much help they can expect in lowering price pressures from improvements in the supply of goods, services and labor, Fed Chair Jerome Powell said on Thursday.

Read More

Related

Business|Sports|Technology

Nike's new CEO may look to fix retailer ties in sales revival push

Nike's new CEO will likely focus on repairing relations with retailers to boost demand, a strategy that took a back seat under outgoing chief John Donahoe, industry

Nike's new CEO may look to fix retailer ties in sales revival push
Business|Europe|News|Travel

Brussels Airlines to cancel most Oct. 1 flights due to strike

Brussels Airlines said on Friday that it would cancel most of its flights on Oct. 1 due to a Belgian national strike of security workers.

Brussels Airlines to cancel most Oct. 1 flights due to strike
Business|Europe|Finance

Germany must oppose UniCredit takeover of Commerzbank, bank employees and union warn

Commerzbank employees and a prominent labour union on Friday called on the German government to oppose a takeover of the German lender by Italy's UniCredit.

Germany must oppose UniCredit takeover of Commerzbank, bank employees and union warn
Share This

Popular

Americas|Business|Sports|Technology

Brazil’s online gambling craze may be hitting consumer spending

Brazil’s online gambling craze may be hitting consumer spending
Asia|Business|Economy|News

China's August youth jobless rate rises to nine-month high

China's August youth jobless rate rises to nine-month high
Business|Economy|Finance

Investment advisers urge clients away from cash after Fed rate cut

Investment advisers urge clients away from cash after Fed rate cut
Business|Europe|Health|Science

Sanofi says tolebrutinib drug delayed progressive MS by 31%

Sanofi says tolebrutinib drug delayed progressive MS by 31%